GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
0
c/retatrutide·posted 1 months ago by u/nadia_trevino

[Meta] proposal — a flair for glucagon posts

Discussion

Putting this to the board: proposal — a flair for glucagon posts.

What the glucagon arm is doing, as best anyone can say from public data.

GLP-1 and GIP agonism cover appetite and insulin secretion in ways that are now reasonably well characterised. Glucagon receptor agonism is the third leg and it is associated with increased energy expenditure and with effects on hepatic fat.

Mechanistically that is why this compound reads as a different proposition rather than a stronger version of a dual agonist. Clinically, the size and durability of that difference in humans is precisely what is not yet established, and anyone telling you otherwise is filling a gap with confidence.

Where the evidence actually stands, since every thread here assumes a different answer.

Phase 2 reported a large mean body weight change at 48 weeks across a few hundred participants with a slow, protocol-driven escalation. The effect size was striking. The confidence intervals were wide, the population was small, and the duration was under a year.

Phase 3 is running. Until it reports, everything else — including the ranking arguments this board loves — is extrapolation from a small study. That is not a criticism of the compound; it is a description of the evidence.

Stopped at a low step because there was no reason to go further and no data to tell me what further would do.

If somebody has the same thing measured a different way, post it next to mine and we will see whether they agree.

0 up / 0 down43% upvoted7 commentsid todvhv23 Jun 2026

7 comments

7 in this archive, depth 4

best — the order this archive was captured in

u/renzo_yildiz4 points·1 months ago·edited

The phase 2 readout ran to 48 weeks in a few hundred participants with a slow escalation. Both the size and the duration matter when people quote the headline number.

replysharereportpermalink
[removed]2 points·1 months ago

[removed by moderator]

replysharereportpermalink
u/arne_amankwah6 points·1 months ago

The phase 2 readout ran to 48 weeks in a few hundred participants with a slow escalation.

Agreed, and the glucagon arm is exactly why the comparison threads do not work.

replysharereportpermalink
u/ewan_zielinski3 points·1 months ago

The food noise profile felt different rather than worse. Hard to describe and impossible to quantify, so take it as an impression.

replysharereportpermalink
u/cagrilintide_enthusiast1 point·1 months ago

Watched heart rate on a wearable across twelve weeks because the threads said to. It moved a little and I have no idea whether that means anything.

replysharereportpermalink
u/signe_villalobos1 point·1 months ago

the escalation is where most of the reported trouble sits

replysharereportpermalink
u/incretin_ivypharmacology1 point·1 months ago

How fast was the escalation? That is usually the variable that explains the reports.

replysharereportpermalink
About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.